Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 891, pseudogene (RNU6-891P) is a non-coding RNA gene classified as a pseudogene, located on chromosome 4 in the human genome[1][3][5][7]. It is named for its sequence similarity to the U6 small nuclear RNA (snRNA), which is a vital component of the spliceosome involved in pre-mRNA splicing in eukaryotic cells[6]. However, as a pseudogene, RNU6-891P is generally considered non-functional and does not produce a functional RNA or protein product[7]. There is no evidence supporting a role for RNU6-891P as a therapeutic target, and it is not known to interact with drugs, serve as a biomarker, or play a role in disease. Context and Supporting Details: - RNU6-891P is recognized by nomenclature authorities (HGNC:47854) as a pseudogene related to U6 snRNA[5]. - U6 snRNA proper is a small nuclear RNA essential for splicing, but pseudogenes like RNU6-891P arise from gene duplication or retrotransposition events and have lost their original function[6][7]. - No biological or disease functions, known drug interactions, or roles as a biomarker are reported for this locus in reviewed genomic resources[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 891, pseudogene (RNU6-891P).